--- title: "GLOBUS MEDICAL INC (GMED) stock: news and investor profile" url: "https://aibio.space/companies/globus-medical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "GLOBUS MEDICAL INC (NYSE: GMED), United States. Listing facts, related biotech companies and news on aibio.space." --- GMED GLOBUS MEDICAL INC NYSE · United States # GLOBUS MEDICAL INC (GMED) news GLOBUS MEDICAL INC is a public biotech or pharmaceutical company listed on NYSE under the ticker GMED, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest GLOBUS MEDICAL INC news We have not published a story on GLOBUS MEDICAL INC yet. When there is news, it will appear here. ## GLOBUS MEDICAL INC at a glance - **Ticker**: GMED - **Listing**: NYSE - **Country**: United States - **Cash, Jun 30, 2026**: $595.1 million ### Related companies - [NovoCure](https://aibio.space/companies/novocure/) NASDAQ: NVCR - [Cannaisseur Group](https://aibio.space/companies/cannaisseur/) OTC: TCRG - [Insight Molecular Diagnostics](https://aibio.space/companies/insight-molecular-diagnostics/) NASDAQ: IMDX - [ORASURE TECHNOLOGIES INC](https://aibio.space/companies/orasure-technologies/) NASDAQ: OSUR - [Personalis](https://aibio.space/companies/personalis/) NASDAQ: PSNL - [GLAUKOS](https://aibio.space/companies/glaukos/) NYSE: GKOS - [CERUS CORP](https://aibio.space/companies/cerus/) NASDAQ: CERS - [ORTHOPEDIATRICS CORP](https://aibio.space/companies/orthopediatrics/) NASDAQ: KIDS ### Also on NYSE - [AMERICAN SHARED HOSPITAL SERVICES](https://aibio.space/companies/american-shared-hospital-services/) AMS - [CHARLES RIVER LABORATORIES INTERNATIONAL, INC.](https://aibio.space/companies/charles-river-laboratories-international/) CRL - [Trulieve Cannabis](https://aibio.space/companies/trulieve-cannabis/) TRLV - [Solventum](https://aibio.space/companies/solventum/) SOLV - [Elanco Animal Health](https://aibio.space/companies/elanco-animal-health/) ELAN - [METTLER TOLEDO INTERNATIONAL INC/](https://aibio.space/companies/mettler-toledo-international/) MTD ## GLOBUS MEDICAL INC annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$2.94 billion](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | [$2.52 billion](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | | Research and development | [$147.2 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | [$163.8 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | | Net income (loss) | [$537.9 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | [$103.0 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | | Cash from operations | [$753.4 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | [$520.6 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | | Cash and equivalents | [$526.2 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026054450/) | [$784.4 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | | Short-term investments | [$31.1 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026054450/) | [$105.6 million](https://www.sec.gov/Archives/edgar/data/1237831/000162828026011209/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $507.7 million, plus short-term investments of $87.4 million, $595.1 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about GLOBUS MEDICAL INC What is the ticker symbol of GLOBUS MEDICAL INC? GLOBUS MEDICAL INC trades under the ticker GMED on NYSE. Where is GLOBUS MEDICAL INC listed? GLOBUS MEDICAL INC is listed on NYSE. Which country or territory is GLOBUS MEDICAL INC listed under? Our directory records GLOBUS MEDICAL INC under United States. Does aibio.space cover GLOBUS MEDICAL INC? aibio.space lists GLOBUS MEDICAL INC among 2,820 public biotech companies and publishes its news here as stories appear. What was GLOBUS MEDICAL INC's revenue last year? $2.94 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is GLOBUS MEDICAL INC profitable? GLOBUS MEDICAL INC reported net income of $537.9 million for the fiscal year ended Dec 31, 2025, and generated $753.4 million of cash from operations, per its annual report to the SEC. How much does GLOBUS MEDICAL INC spend on research and development? $147.2 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does GLOBUS MEDICAL INC have? $595.1 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: GLOBUS MEDICAL INC Members talk about GLOBUS MEDICAL INC (GMED). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:GMED on TradingView](https://www.tradingview.com/symbols/NYSE-GMED/). ## Listing details GLOBUS MEDICAL INC is a public biotech or pharmaceutical company listed on NYSE under the ticker GMED, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: GLOBUS MEDICAL INC - **Ticker**: GMED - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/globus-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "GLOBUS MEDICAL INC (GMED) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/globus-medical/